Ailevi akdeniz ateşi (FMF) hastalığında akut faz yanıtı ile tümör nekrozis faktör-alfa, interlökin-8 ve interlökin-6 düzeylerinin değerlendirilmesi

Çalışmamızda serozal zarların inflamasyon atakları ile karakterize kalıtsal bir hastalık olan ailevi Akdeniz ateşi (FMF) hastalarında atak ve ataksız dönemlerde akut inflamasyonda önemli rol oynayan sitokin düzeylerinin belirlenmesi ve tedavinin sitokin düzeyleri ile akut faz yanıtı üzerine etkisinin araştırılması amaçlanmıştır. Çalışmaya toplam 72 FMF hastası alınmıştır. Hasta grubu tedavi alıp almamalarına ve atak döneminde olup olmamalarına göre 4 gruba ayrılmıştır. Kontrol grubu 20 sağlıklı çocuktan oluşturulmuştur. Çalışmada FMF hastalarında TNF-., IL-8, IL-6 ve akut faz reaktanlarının düzeyi araştırılmıştır. Klasik akut faz reaktanları (fibrinojen, sedimentasyon, CRP) tedavi alan ve almayan hastaların atak dönemlerinde istatiksel olarak anlamlı düzeyde artış göstermiştir. TNF-., IL-6 ve IL-8 düzeyleri kolşisin tedavisinden bağımsız olarak atak ile beraber artmıştır. TNF-. sonuçları , tedavi alan grubun atak döneminde ataksız döneme göre istatiksel olarak anlamlı yüksek saptanmıştır. İL-8 değerleri atak ile beraber artış görülmesine rağmen, gruplar arasında istatiksel olarak anlamlı fark bulunmamıştır. İL-6 değerlerinde de aynı şekilde atak ile beraber artış görülmesine rağmen, gruplar arasında istatiksel olarak anlamlı fark bulunmamıştır.

Acute phase reeponse, levels of TNF-alpha, IL-6 and IL-8 with familial mediterranean fever patients

In our study 72 FMF patients which are divided in to 4 groups were examined. Group 1: 11 patients who were diagnosed as FMF on follow up, not already treated and examined during asymptomatic period, Group 2: 11 patients who were diagnosed as FMF on follow up, not already treated and examined during attacks. Group 3: 27 patients who were diagnosed before the study, colchicine treated and examined during asymptomatic period, Group 4: 23 patients who were diagnosed before the study, colchicine treated and examined during attack. There are 20 healthy children as control group in our study. In each group fibrinogen, erythrocyte sedimentation rate, C-reactive protein, white blood count levels and TNF-á, IL-6, IL-8 concentrations were determined by using ELISA. Fibrinogen, erytrocyte sedimentation rate, Creactive protein levels were increased in treated and untreated patients during attacks. TNF-á, IL-8 and IL-6 levels were found elevated during attacks undependent from colchicine therapy. TNF-á lev- els were found significantly higher in colchicine treated and examined during attacks group than asymptomatic group. In the colchicine treated group IL-8 levels and IL-6 levels were higher during attacks but no statistically meaningfull results were observed. According to our results when compared with control healthy group; TNF-á levels were increased in all patients. Our results suggest that the cytokine network is activated during attacks of FMF. TNF-á appears to play an important role in the evolution of FMF attacks. Because there are great of differences in literature, further studies are needed to elucidate this.

___

  • 1. Ben-Chetrit E, Levy M. Familial Mediterranean fe¬ ver. Lancet 1998;351:659-64.
  • 2. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med. 1945;23:1-21.
  • 3. Heller Hv Sohar E., Sherf L. Familial Mediterranean fever. Arch.lnt.Med. 1958;102:50
  • 4. The French Familial Mediterranean Fever Familial Mediterranean fever Consortium: a candidate gene for FMF. Nat. Genet 1997;17:25-31.
  • 5. The International FMF Consortium. Ancient missen- se mutations in a new nember of the RoRet gene fa¬ mily are likely to cause FMF. Cell 1997;90:797-807.
  • 6. Samuels J., Aksentijevich l.,Torosyan Y., Centola M., Deng Z., Sood R., Kastner D. Familial Mediterrane¬ an fever at the Millennium Clinical spectrum anci¬ ent mutations and a survey of 100 American refer¬ rals to the National Institutes of Health.Medicine 1998;77:268-97.
  • 7. Sohar E, Pras M, Heller J, Heller H. Genetics of fa¬ milial Mediterranean fever (FMF) Arch Int Med. 1961 ;107:109-118.
  • 8. Özdemir AL., Sökmen C, Familial Mediterranean fever among the Turkish people. Am J Gastroenterol 1969;51:311-6.
  • 9. Gabay C, Kushner I. Acute-phase proteins and ot¬ her systemic responses to inflamation The New Eng JMed 1999;340:448-454.
  • 10. Kelly WN et al.(eds). Textbook of rheumatology 4th ed. Philadelphia.W.B. Saunders Chapter 13,1992.
  • 11. Kumar V,et al.(eds):Basic pathology 5th ed. Phila¬ delphia.W.B. Saunders Sf:25-40 1995. 12. Roitt I, Brosstoff J, Male D. Immunology Fourth edi¬ tion . Mosby 1998 9.11, 9.12, 14,8.
  • 13. Beutİer B, Cerami A, The biology of cachectin/TNF- alfa .Ann Rev Immunol 1989;7:625.
  • 14. Lin E, Calvono E, Lowry SF. Inflammatory cytokines and cell response in surgery.Surgery 2000;127
  • 15. W. J. Conover Practical Nonparametric statistics 2ndEd. John Wiley & Sons 1980. Chapter 5, Section 5.2 page: 229-239.
  • 16. Aziz Akgül . Tıbbı Araştırmalarda Istatiksel Analiz Teknikleri-SPSS uygulamaları. Yükseköğretim Kuru¬ lu Matbaası, Ankara 1997.
  • 17. Tunca M, Kırkali G, Soytürk, Akar s, Pepys M, Haw¬ kins P. Acute phase response and evolution of fami¬ lial Mediterranean fever.Lancet (Research let- ters)1999;353(9162):1415
  • 18. Drenth PH, Poland D, Livneh A, van Dijk W. Acute and chronic inflammation in FMF attacks and evi¬ dence for acute phase reaction in MEFV heterozygo- tos(abstract) Clin Exp Rheumatol 2000;18:B-2.
  • 19. Korkmaz C, Özdoğan H, Kasapçopur Ö, Yazıcı H. Acute phase response in familial Mediterranean fe¬ ver. Ann Rheum Dis 2002 ;61:79-81.
  • 20. Özyılkan E, Şimşek H, Telatar H. Tumour necrosis factor in familial Mediterranean fever. Am J Med. 1992;92:579.
  • 21.Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumour necrosis factor in familial Mediterranean fe¬ver. Am J Med. 1991;90:434-8.
  • 22. Gang N, Drenth J.P.H, Livneh A, Langevitz P. Acti¬ vation of the cytokine network in familial Mediterra¬ nean fever. In 1 st International conference on fami¬ lial Mediterranean fever. Program&Abstracts. Jeru¬ salem-Israel, 7-11 September 1997:pp:58 (abst).
  • 23. Erken E, Günesaçar R. Correlation between serum IL-6 and IL-8 levels in familial Mediterranean fever. I st International conference on familial Mediterra¬ nean fever Program&Abstracts. Jerusalem-Israel, 7- II September 1997:pp:60 (abst).
  • 24. Notamicola C, Didelot M.N, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in at¬ tack-free patients with familial Mediterranean fever. Genes Immun 2002 Feb;3(1): 43-45.